DarioHealth
DRIO
46 hedge funds and large institutions have $38.1M invested in DarioHealth in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 5 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
0.21% less ownership
Funds ownership: 2% → 1.79% (-0.21%)
2% less capital invested
Capital invested by funds: $38.9M → $38.1M (-$769K)
2% less funds holding
Funds holding: 47 → 46 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
60% less call options, than puts
Call options by funds: $63K | Put options by funds: $156K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
+$491K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$452K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$214K |
| 4 |
Renaissance Technologies
New York
|
+$197K |
| 5 |
LPL Financial
San Diego,
California
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWAM
Appian Way Asset Management
New York
|
-$595K |
| 2 |
Millennium Management
New York
|
-$539K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$237K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$160K |
| 5 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$148K |
DRIO Hedge Fund Activity: Q1 2023 in Review
46 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2023, worth a combined $38.1M — down 2% from $38.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of DRIO and 4 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 14 added.
The largest buyer was Shay Capital, opening a new position worth an estimated $491K. The largest seller was Appian Way Asset Management, cutting an estimated $595K.
- 46 institutional investors held DarioHealth (DRIO) as of Q1 2023, down from 47 in Q4 2022.
- Funds reported $38.1M of DarioHealth stock for Q1 2023, down 2% quarter-over-quarter.
- 4 funds opened new DarioHealth positions in Q1 2023 and 5 closed out, a net change of -1 holder.
- The largest DarioHealth buyer in Q1 2023 was Shay Capital, an estimated $491K added.
- The largest DarioHealth seller in Q1 2023 was Appian Way Asset Management, an estimated $595K sold.
Based on aggregated 13F filings for Q1 2023.